Login / Signup

Effect of nusinersen on respiratory function in paediatric spinal muscular atrophy types 1-3.

Archana ChackoPeter D SlyRobert S WareNelufa BegumSean DeeganNicole ThomasLeanne M Gauld
Published in: Thorax (2021)
The first year of nusinersen treatment saw reduced lung function decline (especially in type 2) and improvement in AHI.
Keyphrases
  • lung function
  • cystic fibrosis
  • chronic obstructive pulmonary disease
  • air pollution
  • intensive care unit
  • emergency department
  • respiratory tract